Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component"
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu dopisy, komentáře
PubMed
34316009
DOI
10.1038/s41379-021-00876-w
PII: S0893-3952(22)00522-1
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- mutace MeSH
- nádory štítné žlázy * patologie MeSH
- papilární karcinom štítné žlázy patologie MeSH
- papilární karcinom * patologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- komentáře MeSH
Department of Pathology Faculty of Medicine in Plzen Charles University Czechia Czech Republic
Department of Pathology Rutgers University Hospital New Jersey Medical School Newark NJ USA
Department of Pathology The Medical College of Wisconsin Milwaukee WI USA
Zobrazit více v PubMed
Roukain A, Sykiotis GP. CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component. Mod Pathol. 2021. In press.
Suster D, Michal M, Nishino M, Piana S, Bongiovanni M, Blatnik O, et al. Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases. Mod Pathol. 2020;33:1702–11. DOI
